What are the treatment options for dysmenorrhea (menstrual pain)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Menstrual Pain (Dysmenorrhea)

NSAIDs are the first-line treatment for dysmenorrhea, with ibuprofen 600-800 mg every 6-8 hours or naproxen 440-550 mg every 12 hours taken with food for 5-7 days during menstruation. 1, 2, 3

First-Line Pharmacological Treatment: NSAIDs

  • Start ibuprofen 600-800 mg every 6-8 hours or naproxen 440-550 mg every 12 hours, always taken with food 1, 2, 3
  • Treatment duration should be short-term (5-7 days) during days of bleeding only 1, 2
  • For optimal effectiveness, naproxen can be started 2 days before expected menstruation as perimenstrual prophylaxis and continued for 5 days 2
  • NSAIDs work by blocking prostaglandin production, which is the primary cause of menstrual cramping 4, 5
  • Approximately 18% of women will not respond to NSAIDs, requiring investigation for secondary causes 1, 3, 6

Adjunctive Non-Pharmacological Measures

  • Heat therapy applied to the abdomen or back reduces cramping pain and should be recommended alongside NSAIDs 1, 2, 3
  • Acupressure at specific points provides additional pain relief: 1, 2
    • Large Intestine-4 (LI4) point on the dorsum of the hand (bilateral stimulation)
    • Spleen-6 (SP6) point located approximately 4 fingers above the medial malleolus
  • Peppermint essential oil has demonstrated symptom reduction in dysmenorrhea 1, 3

Second-Line Treatment: Hormonal Contraceptives

  • If NSAIDs fail after 2-3 menstrual cycles or are contraindicated, add combined oral contraceptives (COCs) 1, 3
  • Use monophasic formulations with 30-35 μg ethinyl estradiol plus levonorgestrel or norgestimate 1
  • Extended or continuous cycle COCs are particularly appropriate for severe dysmenorrhea as they minimize hormone-free intervals and optimize ovarian suppression 1
  • COCs provide additional benefits including decreased menstrual blood loss and improvement in acne 1
  • Approximately 10% of women will not respond to the combination of NSAIDs and hormonal contraceptives 3, 7

When to Investigate for Secondary Causes

Obtain transvaginal ultrasound if: 3

  • Abnormal pelvic examination findings are present
  • Symptoms suggest secondary dysmenorrhea (pain outside of menstruation, dyspareunia, abnormal bleeding)
  • Failure to respond to appropriate NSAID therapy after 2-3 menstrual cycles
  • Abrupt change in previously stable pain pattern

Rule out the following conditions: 1, 3

  • Pregnancy
  • Sexually transmitted diseases (chronic pelvic inflammatory disease can present as worsening dysmenorrhea)
  • Structural abnormalities (fibroids, polyps, other uterine pathology)
  • Endometriosis or adenomyosis
  • IUD displacement in patients with worsening dysmenorrhea

Management of Suspected Endometriosis

  • Hormonal contraceptives remain first-line for endometriosis-related dysmenorrhea 3
  • If endometriosis is confirmed and medical management fails, GnRH agonists for at least 3 months or danazol for at least 6 months are equally effective 3
  • Add-back therapy with GnRH agonists prevents bone mineral loss without reducing efficacy 3
  • Medical therapy alone may be insufficient for severe endometriosis 3

Critical Pitfalls to Avoid

  • Do not underdose NSAIDs - higher doses (ibuprofen 600-800 mg) are more effective than lower doses in clinical practice 3, 4
  • Do not delay NSAID treatment while waiting for diagnostic workup 3
  • Do not continue ineffective treatment beyond 2-3 cycles - this indicates need for alternative therapy or investigation 3
  • Do not use NSAIDs without food - this increases gastrointestinal adverse effects 1, 2, 3
  • Use the lowest effective dose for the shortest duration, and exercise caution in patients at risk for bleeding or with renal impairment 2

Adverse Effects Profile

  • NSAIDs carry a 29% increased risk of overall adverse effects compared to placebo 8
  • Gastrointestinal adverse effects occur with 58% increased risk 8
  • Neurological adverse effects (headaches, drowsiness) occur with 174% increased risk 8
  • If 10% of women taking placebo experience side effects, between 11-14% taking NSAIDs will do so 8

References

Guideline

First-Line Treatment for Dysmenorrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medication Management for Menstrual Cramps

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Chronic Dysmenorrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Dysmenorrhea.

Annals of the New York Academy of Sciences, 2000

Research

Primary dysmenorrhea.

American family physician, 1999

Research

Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.

The Cochrane database of systematic reviews, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.